Knight Cardiovascular Institute, Department of Chemical Physiology and Biochemistry, and Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland.
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):999-1011. doi: 10.1161/ATVBAHA.120.314647. Epub 2021 Jan 14.
Platelets rapidly undergo responsive transitions in form and function to repair vascular endothelium and mediate hemostasis. In contrast, heterogeneous platelet subpopulations with a range of primed or refractory phenotypes gradually arise in chronic inflammatory and other conditions in a manner that may indicate or support disease. Qualitatively distinguishable platelet phenotypes are increasingly associated with a variety of physiological and pathological circumstances; however, the origins and significance of platelet phenotypic variation remain unclear and conceptually vague. As changes in platelet function in disease exhibit many similarities to platelets following the activation of platelet agonist receptors, the intracellular responses of platelets common to hemostasis and inflammation may provide insights to the molecular basis of platelet phenotype. Here, we review concepts around how protein-level relations-from platelet receptors through intracellular signaling events-may help to define platelet phenotypes in inflammation, immune responses, aging, and other conditions. We further discuss how representing systems-wide platelet proteomics data profiles as circuit-like networks of causally related intracellular events, or, pathway maps, may inform molecular definitions of platelet phenotype. In addition to offering insights into platelets as druggable targets, maps of causally arranged intracellular relations underlying platelet function can also advance precision and interceptive medicine efforts by leveraging platelets as accessible, dynamic, endogenous, circulating biomarkers of vascular wellness and disease. Graphic Abstract: A graphic abstract is available for this article.
血小板在形态和功能上迅速发生反应性转变,以修复血管内皮并介导止血。相比之下,在慢性炎症和其他情况下,会逐渐出现具有一系列预激活或难治表型的异质血小板亚群,这可能表明或支持疾病的发生。可定性区分的血小板表型与各种生理和病理情况越来越相关;然而,血小板表型变异的起源和意义仍不清楚,概念上也很模糊。由于疾病中血小板功能的变化与血小板激动剂受体激活后的血小板表现出许多相似之处,因此止血和炎症共有的血小板细胞内反应可能为血小板表型的分子基础提供一些见解。在这里,我们回顾了有关蛋白水平关系的概念——从血小板受体到细胞内信号事件——如何帮助定义炎症、免疫反应、衰老和其他情况下的血小板表型。我们进一步讨论了如何将系统范围的血小板蛋白质组学数据图谱表示为具有因果关系的细胞内事件的类电路网络,或途径图谱,以告知血小板表型的分子定义。除了为血小板作为可药物治疗的靶点提供见解外,作为可及、动态、内源性、循环血管健康和疾病生物标志物的血小板,其细胞内因果关系图谱还可以通过利用血小板来推进精准医学和干预性医学的努力。